Project Grant R34AT009678

This federal Project Grant award of $2,398,281.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program aims to increase access to evidence-based PTSD treatment for military service members and veterans through Behavioral Health Technician-delivered Written Exposure Therapy (WET). The primary awardee, Palo Alto Veterans Institute for Research (Pavir), will oversee the overall project objectives, which include providing WET training to...

This $2.9 million Defense Health Agency project grant funds research on suicide prevention among military personnel and veterans. The grant supports a multi-site randomized clinical trial through September 2026 to evaluate the efficacy of Written Exposure Therapy for Suicide Prevention compared to treatment as usual. Researchers at Boston University and partner institutions University of Colorado Denver and University of Texas Health Science Center San Antonio aim to reduce suicidal thoughts and...

Boston University Medical Campus received a $567,000 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 8, 2025, with completion targeted for September 7, 2028. The grant funds research to augment Cognitive Processing Therapy (CPT) with peer-led support interventions designed to improve mental well-being and enhance PostTraumatic Stress Disorder (PTSD) recovery outcomes in vulnerable populations....

The Department of the Army Medical Command awarded a $5.95 million cooperative agreement to The Johns Hopkins University on September 30, 2022 under the Military Medical Research and Development program (CFDA 12.420). The four-year award will fund a randomized controlled trial to evaluate cognitive-behavioral therapy versus mindfulness-based treatment for insomnia and post-traumatic stress symptoms related to traumatic brain injury. Sub-awards were provided to The Henry M. Jackson Foundation For...

This $3,823,679 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and evaluation of a web-based training program for brief cognitive behavioral therapy (BCBT) for suicide prevention. The prime awardee, The Ohio State University, is collaborating with subrecipients The University of Texas Health Science Center at San Antonio, the Medical University of South Carolina, and the University of Memphis...

The University of Texas Health Science Center of San Antonio will receive $3 million in cooperative agreement funding from the Department of the Army Medical Command to conduct a randomized clinical trial combining stellate ganglion block with prolonged exposure therapy for post-traumatic stress disorder (PTSD). The four-year award under the Military Medical Research and Development program (CFDA 12.420) aims to investigate medical solutions for traumatic battlefield injuries and transform...

This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...

This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...

The East Bay Institute For Research & Education Inc. was awarded a $1.9 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research study from September 2022 through September 2026 to compare the effectiveness of mindfulness-wellness classes versus brain health education for veterans with mild traumatic brain injury (MTBI). The Military Medical Research and Development...

The Department of the Army Medical Command awarded a $7.286 million cooperative agreement to New York University School of Medicine to advance precision psychiatry for military service-related post-traumatic stress disorder (PTSD) by enhancing knowledge of clinical subtypes and their endophenotypes. Funded under the Military Medical Research and Development program (CFDA 12.420), this four-year cooperative agreement aims to transform military and public health care through innovative...